| Literature DB >> 36004978 |
Abstract
Currently, several biosensors are reported to confirm the absence/presence of an abnormal level of specific human biomarkers in research laboratories. Unfortunately, public marketing and/or pharmacy accessibility are not yet possible for many bodily fluid biomarkers. The questions are numerous, starting from the preparation of the substrates, the wet/dry form of recognizing the (bio)ligands, the exposure time, and the choice of the running buffers. In this context, for the first time, the present overview summarizes the pre-functionalization of standard and nanostructured solid/flexible supports with cysteamine (Cys) and glutaraldehyde (GA) chemicals for robust protein immobilization and detection of biomarkers in body fluids (serum, saliva, and urine) using three transductions: piezoelectrical, electrochemical, and optical, respectively. Thus, the reader can easily access and compare step-by-step conjugate protocols published over the past 10 years. In conclusion, Cys/GA chemistry seems widely used for electrochemical sensing applications with different types of recorded signals, either current, potential, or impedance. On the other hand, piezoelectric detection via quartz crystal microbalance (QCM) and optical detection by surface plasmon resonance (LSPR)/surface-enhanced Raman spectroscopy (SERS) are ultrasensitive platforms and very good candidates for the miniaturization of medical devices in the near future.Entities:
Keywords: biofunctionalization of substrates; biomarkers; biosensors; cysteamine (Cys); electrochemistry; glutaraldehyde (GA); optics; quartz crystal microbalance (QCM)
Mesh:
Substances:
Year: 2022 PMID: 36004978 PMCID: PMC9406156 DOI: 10.3390/bios12080581
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1Solid and flexible electrodes used for functionalization with biological molecules and their use for piezoelectrical, electrochemical, and optical biomarker investigations. SPE—screen-printed electrodes; PDMS—poly-dimethylsiloxane.
Figure 2Stepwise immobilization of proteins on the gold substrate using relatively inexpensive cysteamine (Cys)/glutaraldehyde (GA) reagents. Three (bio)functionalization steps are required: (1) incubation with aqueous/ethanol Cys solution; (2) incubation with aqueous GA solution; and (3) incubation with proteins from various human biological fluids such as whole blood, serum, saliva, and urine.
Step-by-step (bio)functionalization of supports for piezoelectric detection of biomarkers on different various substrates.
| Electrode | Size (Ø) | Cleaning | Cys Activation | GA Activation | Buffer | Ab | Incubation Time/°C (Ab) | Blocking Sites | Storage | Ag | Detection Method | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ag-QCM | 5 mm | 0.5 M NaOH + acetone + methanol for 30 min + DI water + drying at 37 °C for 30 min | 18 mM Cys in 0.1 M PBS pH 7 for 2 h in dark | 0.66 M in sodium tetraborate/HCl buffer pH 8.2 for 2 h in dark | 0.1 M PBS, pH 7.4 (for dil.) | 1/10,000 ( | RT | x | Stock solutions at 4 °C for one week before use | 10 μM–50 μM Hcy (3 mL) for 30 min on stirred at RT | QCM | [ |
| Au-QCM | 8 mm | 1:3 mixture of 30%, ( | 25 mM Cys in ethanol for 2 h (static regime) + PBS flow 4 min | 2.5% ( | 0.01 M PBS *, | x | cTnT in PBS or serum 800 s (static regime) + PBS wash at flow 100 μL/min for 4 min at 25 °C | QCM | [ | |||
| AuQCM | 0.8 cm | 0.5 M NaOH for 3 min + 3 × washing with ethanol and DI water | 50 mM Cys in PBS (pH 7.4) for 2 h, at RT | 2.5% ( | PBS | Canine serum positive to | 15 min | 50 mM glycine | 4 to 8 °C | 3 × 106 pg/mL rLci2BNH6 antigen for 1 h | QCM | [ |
| Au-QCM | 5 mm | Acetone for 30 min + drying | 10 × 109 pg/mL Cys for 2 h (20 μL) | 3% GA in water for 2 h | Wash: PBS/0.5% Triton x 100/PBS | Sera sample for 10 min (20 μL) | RT | 10 × 109 pg/mL BSA | x | 1 × 109 pg/mL Ag (lipid fraction from liver cells) + overnight at 4 °C (20 μL) | QCM | [ |
Abbreviations: Ab—antibody; Ag—antigen; cTnT—human cardiac troponin T; Hcy—homocysteine; mAb-cTnT—mouse monoclonal antibody against cTnT; * PBS: 0.2 g KCl, 8.0 g NaCl, 0.24 g KH2PO4, 1.44 g Na2HPO4, in 1000 mL UPW; chronological modification of supports: (1) to (10) for different biosensing schemes.
Step-by-step (bio)functionalization of supports for electrochemical detection of biomarkers on different solid and flexible substrates.
| Electrode | Size (Ø) | Cleaning | Cys Activation | GA Activation | Dilution Buffer | Ab | Incu-bation Time/°C (Ab) | Blocking the Non-Specific Sizes | Storage | Ag2 | Detection Method | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Au disc (GDE) | 1.6 mm | 30% H2O2; conc H2SO4, | 10 mM Cys in an ethanolic solution for 16 h at 25 °C | 2.5% GA for 60 min | 0.05 M PBS, pH 7.4 | Anti-GLY Ab 10 × 106 pg/mL 40 min | 1 h at 37 °C | 2% BSA (0.05 M PBS, pH 7.4, for 30 min at 25 °C | 4 °C in PBS (pH 7.4) (after 30 days) 9% loss for 10 ng GLY Ag | GLY protein 103–106 pg/mL for 30 min at 25 °C | SWV | [ |
| Au | 3 mm | SR + Al2O3 < 50 nm + Drops UPW + UPW + absolute ethanol (99.9%) for 5 min + UPW for 5 min in the ultrasonic + dried with pure Ar | 100 mM Cys in absolute ethanol for 1 h | 1% GA for 10 min + 1.5% PAMAM in methanol for 1 h | UPW + AS | 2.5 ng/anti-TSH for 1 h (5 µL) | 1 h | x | x | 0.1–0.6 mIUL−1 TSH in artificial serum (AS) | EIS | [ |
| Au | 2 mm | Polished with 0.3 and 0.05 mm alumina slurry + acetone/water (1:1) for 30 min + 0.1 M H2SO4 | 10 mM solution Cys in 1 mM ethanol 200 µL, 3 h in dark at RT | GA for 30 min RT | 0.1 M PBS pH 7 | Anti-Cyfra 21.1 Ab (50 µL) | 12 h at 4 °C | BSA for 1 h | 4 °C | Cyfra 21.1 Ag (2.5, 5, 10, 25, 50) × 103 pg/mL human saliva | SWV | [ |
| Au | x | 0.1 M H2SO4 + CV + polish with alumina slurry, sized 1.0, 0.3, 0.05 µm | 100 mM aqueous Cys for 1 h (20 μL) + wash DI water | 2.5 % GA in WEB (20 μL) + 100 × 106 pg/mL Ab in WEB (20 μL) | 0.05 M PBS pH 7.4 (WEB) | x | x | x | x | DPV: (2.5, 10, 25, 50, 100, and 200) × 103 pg/mL WEB DHEA−S (10 μL) for 30 min | DPV | [ |
| Au | x | 0.1 M H2SO4 + 15 CVs | 10 mM Cys fo1r 1 h + drying | GA for 1 h | PBS, pH 7.4 | x | x | x | 4 °C for 24 h | 60 CVs for polymerization 0.5 mM TB*c in PBS (pH 7.4) + PSA (1–60) × 103 pg/mL | DPV | [ |
| Au | 1.6 mm | 0.05 and 0.3 µm alumina + rinsed with ddwater + 0.1 M H2SO4 + H2O2/H2SO4, 1/3 | 10 mM Cys in absolute ethanol for 3 h in dark | 2.5% GA in water for 30 min (200 µL) | PBS, pH 7 | 10 µg/mL (200 µL) | Over-night at 4 °C | 1% milk 1 h at RT | x | Depleted plasma (pg/mL to ×106 pg/mL) for 15 min | EIS | [ |
| AuNps inks/carbon ink/polyimide sheet + 150 °C for 10 min | ≈2 mm2 electrode with < 60 nm AuNps | Polyimide: ultrasonication with acetone | 20 mM Cys for 30 min(5 µL) + ddwater + N2 dry | 4% GA for 30 min (5 μL) + ddwater + | DI water vs. PBS, pH 7.4 | x | x | x | x | 7 × 109 pg/mL GOx (5 μL) overnight | ChA | [ |
| Au | 2.01 mm2 | Polished with 0.05 μm alumina + ultrasonicaltion in ethanol for 5 min | 0.5 M Cys in pure ethanol overnight in dark | 5% GA (5 µL) + 5 × 109 pg/mL anti-HER-3 (5 μL) for 1 h in wet atm | Sterile 0.01 M PBS (pH 7) | x | x | 1% BSA (10 μL) for 1 h in wet atm | Anti-HER-3 and HER-3 solutions at −20 °C | 0.2 to 1.0 pg/mL HER-3 solution (5 μL) for 1 h in wet atm | EIS | [ |
| Carbon + AuNPs by electro-deposition | x | x | Cys | 2.5% ( | x | Anti-STAT3, anti-PGM3, anti-DOCK8 10 × 106 pg/mL PBS, pH 8.5 | 1 h | 0.1 M ethanol-amine for 30 min | 4 °C | 1 pg/mL to 105 pg/mL STAT3 | SVW | [ |
| GCE | 3 mm | 0.3µm and 0.05 µm Al2O3 slurry + Ultrason (59 kHz, 200 W) with UPW + absolute ethanol + BP (3 μL) + PG (4.2 μL) + IR dried + AuNP solution in dark for 24 h | 60 mM Cys in pure ethanol + overnight in the dark | 0.1% GA for 15 min | 0.1 M PBS, pH 7.4 | 20 × 103 pg/mL | In dark for 120 min | 1% BSA (10 μL) | 4 °C for 1 week | 0.15, 1, 10, 100, 312, 625, 1250 and 2500 pg/mL leptin for 2 h | SWV | [ |
| Graphite pencils | 1 cm lengh (Ø 0.7 mm) | Polish sand-paper (2000-grit) | AuNP-Cys (pH 7.4) for 75 min | 2.5% ( | 0.1 M PBS, pH 7.4 | x | 30 min at 37 °C | 1% BSA ( | 4 °C dry (stable 24 h) or in PBS (pH 7.4) (stable for 120 h) | SARS-CoV-2 spike protein (SP) | SWV | [ |
| GCE | Au clusters on GCE after 20 CV cycles of Au solution | 0.05 µm alumina suspension on felt + water rinsing + ultasonic ethanol/water (1:1) for 5 min | 20 mM Cys for 1 h (25 μL) | 7.5% GA in dimethyl formamide for 1 h (25 μL) | PBS tablet: 0.01 M PBS + 0.0027 M KCl + 0.137 M NaCl (pH 7.5) at 25 °C | (0.1–1000) × 10−6 pg/mL 0.01 M (pH 7.5) PBS solution anti-spike antibody | 30 min at RT | 2% BSA for 20 min | 4 °C | 5 × 106 pg/mL SARS-CoV-2 (2019-nCoV) spike S1-his recombinant protein for 45 min (10 μL) | SWV | [ |
| GSPE | 2 mm | Acetone 15 min | 20 × 109 pg/mL Cys in water (2 μL) for 2 h at RT | 5% GA in PBS for 1 h at RT | *AB PBS + filtered through 0.22 μm PES mb | 0.81 × 109 pg Ab/mL−1 PBS | Over-night at 4 °C | 1% BSA in AB for 1 h at RT | 4 °C (dry electrode with Ab) | Ampe-rometry + H2O2/1 mM TMB | [ | |
| GCE | 4 mm | 0.3 μm and 0.05 μm alumina slurries + sonication in distilled water and ethanol for 2 min + dry in the air | 0.1 M Cys for 12 h at 4 °C | 2.5% GA for 2 h | 0.01 M PBS pH 7.4 | MC-LR-BSA conjugate 50 × 106 pg/mL (5 μL) | 6 h at 4 °C | 0.01 M PBS pH 7.4 + 2 wt % BSA for 1 h at RT (5 µL) | Dry at 4 °C | 10 to 105 pg/mL MC-LR (2.5 μL) + 100 × 106 pg/mL HRP-mAb (2.5 μL) for 40 min at RT | EIS | [ |
| GSPE | 2 mm | Acetone for 20 min | 20 × 109 pg/mL−1 Cys in water 2 h | 3% in PBS for | Filtered PBS, pH 7.4 | 100 × 106 pg/mL in PBS | Over-night at 4 °C | BSA in PBS + 0.01% Tween 20 or milk 30 min | Dry at 4 °C | 103–108 CFU/mL Salmonella in tube 1 mL or 10 µL in PBS or milk 15 min RT | EIS | [ |
| PCB | Formation 75–100 nm AuNPs | EC and AC ** | 10 mM Cys in absolute ethanol (20 µL) | 2.5% ( | 1 × filtered PBS * | SARS-CoV-2 spike protein polyclonal Ab (10 × 106 pg/mL, 10 µL) | 12 h at 4 °C | 1% BSA (7 µL) 3 h at 4 °C | 4 °C | Spike protein 0.1 × 103 pg/mL to 500 × 103 pg/mL. 7 µL for 5 min | DPV | [ |
| NC-mb + 0.2% CHIT (in 2% acetic acid) for 24 h at RT + 10% methanol + 30 min drying | Preparation: urease NPs (ethane/urease = 2:1) 20–100 nm NPs pH 5.5 vs. 13 nm urease pH 7 | x | 0.12 g Cys under stirring for 5–6 h | 2.5% GA stirring 500 rpm at 4 °C for 24 h | 0.1 M sodium acetate buffer, pH 5.5 | x | x | x | WM in 0.1 M sodium acetate buffer, pH 5.5, at 4 °C | Urea 2 to 80 µM in 0.1 M sodium acetate buffer, pH 5.5, at 40 °C | Poten-tiometry | [ |
Abbreviations: Ab—antibody; Ag—antigen; AISE—ammonia ions selective electrode; BB—blocking buffer; BP—black phosphorous; BSA—bovine serum albumin; CFU—colony-forming unit; ChA—chronoamperometry; CHIT—chitosan; Cys—cysteamine; DHEA—dehydroepiandrosterone 3-sulfate; DPV—differential pulse voltammetry; EIS—electrochemical impedance spectroscopy; EDC—N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride; GA—glutaraldehyde, GCE—glassy carbon electrode; GSPE—gold screen printed electrode; NHS—N-hydroxysuccinimide; MC-LR—microcystin with leucin and arginine; RT—room temperature; TMB—3,3′,5,5′-tetramethylbenzidine; BGG—bovine γ-globulin; PCB—printed circuit board modified with 35 μm copper layer/3–5 μm nickel/75–100 nm gold; PG—porous graphene; PVA—poly(vinyl alcohol; SWV—square wave voltammetry; WM—working nitrocellulose membrane; WEB—working buffer. * PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4; PBS—phosphate-buffered saline. ** AC—ammonium hydroxide mixed with hydrogen peroxide for cleaning electrodes in two steps: (i) acetone, ethanol, and DI water (1:1:1) for 20 min and (ii) NH4OH:H2O2:DI water = 1:1:5 for 20 min, providing more DPV electroactive signals when compared with electrodes cleaned with EC—absolute ethanol cleaning for 20 min; GLY—glycodelin; NC—nitroce-llulose. *AB, PBS—assay buffer (pH 7.5): 0.2% BSA, 0.5% BGG, 50 mM Tris, 150 mM NaCl, 5 mM EDTA, 0.2% PVA, 1% glucose, and 0.01% Tween 20; HRP-Ab—anti-Melissococcus antibody with HRP, PBS: pH 7.4, 50 mM NaH2PO4/Na2HPO4+150 mM NaCl; PAMAM—polyamidoamine dendrimer; SR—synthetic rayon; UPW—ultra-pure water; TSH—thyroid-stimulating hormone. Chronological modification of supports: (1) to (10) for different biosensing schemes.
Figure 3Functionalization of working electrode with AuNPs (yellow circle) and different chemicals cysteamine (1), glutaraldehyde (2), anti-spike protein antibody (3), BSA blocking reagent (4) and SARS-CoV-2 spike protein (5).
Figure 4Construction of immunosensor and recorded SWV signals of healthy (absence—blue) and infected (presence—violet) patients with SARS-CoV-2 spike protein.
Step-by-step (bio)functionalization of supports for optical detection of biomarkers on different solid and flexible substrates.
| Electrode | Size Ø | Cleaning | Cys Activation | GA Activation | Dilution/Washing Buffer | Ab | Incubation Time/°C (Ab) | Blocking Sites | Storage | Ag/Analyte | Detection Method | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AuNPs on quartz fibers | 40–60 nm | x | 20 mM Cys in 95% ethanol for 1 h (10 μL) | GA for 15 min (for SEM) | UPW | x |
| x |
| 100 × EV in UVW for 2 h at RT (40 μL) | SERS | [ |
| NSF10 glass | 5 nm Ti + 45 nm Au | Sonication in acetone/ethyl (10 min) + rinsed DIW + ethyl alcohol (5 min) + N2 drying | 1 mM Cys for 24 h + 30 nm AuNPs at 50 °C to obtain 5OD | x | x | 500 nM IgG + ethyl alcohol and distilled water for 10 min | x | x | x | 4-ABT 10−8 to 10−4 M for 30 min + ethyl alcohol and distilled water for 5 min | SERS & LSPR | [ |
| Au filmed PDMS | 1 cm2 | Glass slide: UV ozone for 20 min + PS + PDMS + 1 h at 60 °C Pelled off PDMS + DMF Coating: 50 nm Au | 0.2 M Cys aqueous solution in dark at RT for 15 h | 4% GA at RTfor 4 h | PBS pH 7.4 | Anti-human IgG 1.5 × 106 pg/mL (50 μL) | 4 h | 5 × 109 pg/mL of BSA in PBS for 1 h | x | 1 × 109 pg/mL human IgG in PBS (pH 7.4) at 20 °C for 15 h | LSPR & SERS | [ |
| Glass slide + 5 nm Cr + 50 nm Au |
| 1.2 M NaOH for 10 min + 1.2 M HCl for 5 min + one drop of HCl for 30 s | 10 mM Cys in 50 mM PBS, pH 7.0, for 1 h + DI + PBS + dry | 10% GA ( | PBS * + DI water + dry | 1 × 109 pg/mL anti-ferritin MAbs | 1 h | 0.1 M glycine in 50 mM PBS pH 7.0 for 30 min | Signal stability for 15 days | Human ferritin 0.2 × 103–200 × 103 pg/mL for 30 min (3 µL) | SPR | [ |
Abbreviations: DMF—dimethylformamide; EV—extracellular vesicles; SEM—scanning electron microscopy; OD—optical density; 4-ABT—4-aminobenzenethiol; * PBS composition: 5 mM Na2HPO4/NaH2PO4, 0.15 M NaCl; pH 7.0. Chronological modification of supports: (1) to (10) for different biosensing schemes.